当前位置: 首页 > 详情页

Chiglitazar Added to Metformin for Type 2 Diabetes

文献详情

编号/登记号:
注册时间:
研究开始时间:
研究结束时间:
项目类型:
本院角色:
多中心研究:
招募状态:
试验分期:
研究疾病/适应症:
研究类型:
研究负责人:
研究单位: [1]Chipscreen Biosciences, Ltd. [2]Peking University People's Hospital [3]Hefei Second People's Hospital,Hefei, Anhui, China [4]The First Affiliated Hospital of Anhui Medical University,Hefei, Anhui, China [5]The Second Affiliated Hospital of Anhui Medical University,Hefei, Anhui, China [6]Yijishan Hospital of Wannan Medical College,Wuhu, Anhui, China [7]Beijing Chaoyang Hospital, Capital Medical University,Beijing, Beijing, China [8]Beijing Friendship Hospital, Capital Medical University,Beijing, Beijing, China [9]Beijing Luhe Hospital, Capital Medical University,Beijing, Beijing, China [10]Beijing Tongren Hospital, Capital Medical University,Beijing, Beijing, China [11]Beijing Tsinghua Chang Gung Memorial Hospital,Beijing, Beijing, China [12]Beijing University First Hospital,Beijing, Beijing, China [13]Chinese People's Liberation Army Rocket Army Characteristic Medical Center,Beijing, Beijing, China [14]Peking University People's Hospital,Beijing, Beijing, China [15]Xuanwu Hospital, Capital Medical University,Beijing, Beijing, China [16]The Second Affiliated Hospital of Chongqing Medical University,Chongqing, Chongqing, China [17]Three Gorges Hospital Affiliated to Chongqing University,Wanzhou, Chongqing, China [18]Shenzhen People's Hospital,Shenzhen, Guangdong, China [19]Union Shenzhen Hospital of Huazhong University of Science and Technology,Shenzhen, Guangdong, China [20]Harrison International Peace Hospital,Hengshui, Hebei, China [21]The Second Hospital of Hebei Medical University,Shijia Zhuang, Hebei, China [22]The Third Hospital of Hebei Medical University,Shijia Zhuang, Hebei, China [23]Huaihe Hospital of Henan University,Kaifeng, Henan, China [24]The First Affiliated Hospital of Henan University of Science and Technology,Luoyang, Henan, China [25]The Third People's Hospital of Luoyang City,Luoyang, Henan, China [26]Xinxiang Central Hospital,Xinxiang, Henan, China [27]The First People's Hospital of Chenzhou City,Chenzhou, Hunan, China [28]Yueyang Second People's Hospital,Yueyang, Hunan, China [29]Zhuzhou Central Hospital,Zhuzhou, Hunan, China

研究目的:
The purpose of the trial is to evaluate the effect of Chiglitazar added to metformin to type 2 diabetes Inadequately controlled with metformin Monotherapy.

资源点击量:16996 今日访问量:0 总访问量:905 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院